Preclinical profile of zofenopril: An angiotensin converting enzyme inhibitor with peculiar cardioprotective properties

被引:60
作者
Subissi, A [1 ]
Evangelista, S [1 ]
Giachetti, A [1 ]
机构
[1] Menarini Ric SPA, Preclin Dev, I-50131 Florence, Italy
来源
CARDIOVASCULAR DRUG REVIEWS | 1999年 / 17卷 / 02期
关键词
angiotensin-converting enzyme inhibitor; cardioprotection; hypertension; sulfhydryl; zofenopril;
D O I
10.1111/j.1527-3466.1999.tb00008.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:115 / 133
页数:19
相关论文
共 44 条
[1]   THE EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ZOFENOPRIL ON MORTALITY AND MORBIDITY AFTER ANTERIOR MYOCARDIAL-INFARCTION [J].
AMBROSIONI, E ;
BORGHI, C ;
MAGNANI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02) :80-85
[2]   Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart [J].
Anning, PB ;
Grocott-Mason, RM ;
Lewis, MJ .
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH, 1997, 5 (04) :265-275
[3]   ENHANCED PROSTAGLANDIN PRODUCTION IN THE ISCHEMIC-REPERFUSED MYOCARDIUM BY CAPTOPRIL LINKED WITH ITS FREE-RADICAL SCAVENGING ACTION [J].
BAGCHI, D ;
IYENGAR, J ;
STOCKWELL, P ;
DAS, DK .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1989, 38 (02) :145-150
[4]  
BENNET T, 1993, RENIN ANGIOTENSIN SY, V98, P1
[5]  
Brogelli L, 1999, FASEB J, V13, pA528
[6]   Angiotensin-converting enzyme inhibitors [J].
Brown, NJ ;
Vaughan, DE .
CIRCULATION, 1998, 97 (14) :1411-1420
[7]   ANTIOXIDANT EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS - FREE-RADICAL AND OXIDANT SCAVENGING ARE SULFHYDRYL DEPENDENT, BUT LIPID-PEROXIDATION IS INHIBITED BY BOTH SULFHYDRYL-CONTAINING AND NONSULFHYDRYL-CONTAINING ACE INHIBITORS [J].
CHOPRA, M ;
BESWICK, H ;
CLAPPERTON, M ;
DARGIE, HJ ;
SMITH, WE ;
MCMURRAY, J .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 (03) :330-340
[8]   COMPARISONS INVITRO, EXVIVO, AND INVIVO OF THE ACTIONS OF 7 STRUCTURALLY DIVERSE INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME (ACE) [J].
CUSHMAN, DW ;
WANG, FL ;
FUNG, WC ;
GROVER, GJ ;
HARVEY, CM ;
SCALESE, RJ ;
MITCH, SL ;
DEFORREST, JM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 :S115-S131
[9]   DIFFERENTIATION OF ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS BY THEIR SELECTIVE-INHIBITION OF ACE IN PHYSIOLOGICALLY IMPORTANT TARGET ORGANS [J].
CUSHMAN, DW ;
WANG, FL ;
FUNG, WC ;
HARVEY, CM ;
DEFORREST, JM .
AMERICAN JOURNAL OF HYPERTENSION, 1989, 2 (04) :294-306
[10]   PRECLINICAL PHARMACOLOGY OF ZOFENOPRIL, AN INHIBITOR OF ANGIOTENSIN-I CONVERTING ENZYME [J].
DEFORREST, JM ;
WALDRON, TL ;
KRAPCHO, J ;
TURK, C ;
RUBIN, B ;
POWELL, JR ;
CUSHMAN, DW ;
PETRILLO, EW .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 (06) :887-894